2004 Annual Meeting | Pharmacologic Approaches to Pain Management

Date Monday 04/26/04

Time 06:30 PM - 09:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Dinner Seminar

Director(s) Marco Pappagallo, MD

Topic(s) Headache/Other Pain Syndromes

Learning Objectives Upon completion:
Participants should be able to describe the pharmacotherapeutic options available in the management of chronic pain; be aware of the novel concept of adding low doses of opioid antagonists to opioid analgesics in order to enhance opioid analgesia; be familiar with the use of topical analgesics; and develop a rational approach to the management of spinal pain.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
06:30 PM - 07:15 PM		Introduction to the Contemporary Pharmacological Management of Chronic Pain Marco Pappagallo, MD
07:15 PM - 07:50 PM		Controversies in Pain Medicine: Low Dose Opioid Antagonists to Enhance Opioid Analgesia, Manage Hyperalgesia, and Reverse Tolerance Ricardo Cruciani, MD
07:50 PM - 08:25 PM		Analgesics: Focus on Topical Approaches Charles E. Argoff, MD
08:25 PM - 09:00 PM		Spinal Pain: A Neurologist's Perspective Anthony H. Wheeler, MD
09:00 PM - 09:30 PM		Questions and Answers

Faculty Disclosures
Marco Pappagallo, MD	No disclosure on file
Ricardo Cruciani, MD	No disclosure on file
	No disclosure on file
Charles E. Argoff, MD	Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nevro. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for XGene. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Colllegium. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Argoff has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Argoff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. Dr. Argoff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Scilex. The institution of Dr. Argoff has received research support from Lilly. The institution of Dr. Argoff has received research support from Lundbeck. The institution of Dr. Argoff has received research support from Abbvie. The institution of Dr. Argoff has received research support from Vertex. Dr. Argoff has received publishing royalties from a publication relating to health care.
Anthony H. Wheeler, MD	No disclosure on file

��ɫ��

��ɫ��